Bayer shares gain as another activist investor piles in

is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to a five-week high.

Bluebell is also seeking to have supervisory board Chairman Norbert Winkeljohann and Chief Executive Officer Werner Baumann replaced, the person said. A stalwart of German industry with a nearly 160-year history, Bayer has lost over 40% of its market value since its 2018 takeover of Monsanto, which was followed by a string of lawsuits over allegations that Monsanto's Roundup weedkiller causes cancer.Inclusive Capital PartnersA third activist investor, Elliott Management, took a 1.1 billion euro stake in Bayer in 2019 but has since kept a low profile.

Awww hell....what does HE know...that the rest of us DON'T?!!! 🤔🤔

🤣😂

Bayer supporting the Indian governments brahmisim policy by depriving the sc/st, obc ,minorities and women by its recent research scholarships which are reserved for EWS category of upper caste..

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bayer shares gain on prospect of second activist pushing for changeBayer is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to a five-week high.
Source: Reuters - 🏆 2. / 97 Read more »

Breakingviews - Bayer’s rude health lays better path for breakupBayer’s crop of improving businesses looks ripe for a split. The $58 billion drugs-to-seeds conglomerate has for years traded at a hefty discount to the sum of its parts, but refused to do anything about it. Activists like Jeff Ubben’s Inclusive Capital Partners may now, however, be in a better position to push for a breakup.
Source: Reuters - 🏆 2. / 97 Read more »